Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation.

[1]  G. Gasparini,et al.  Clinical studies with angiogenesis inhibitors: biological rationale and challenges for their evaluation. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  S. Fox,et al.  Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  G. Viale,et al.  Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas , 1996, International journal of cancer.

[4]  Chul Ahn,et al.  Endothelial area as a prognostic indicator for invasive breast carcinoma , 1996, Cancer.

[5]  M. Toi,et al.  Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  T. Nose,et al.  Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. , 1996, Cancer research.

[7]  Benoit Vf.  Clinical problem-solving: if at first you don't succeed. , 1996, The New England journal of medicine.

[8]  J. Wang,et al.  CD 105 and angiogenesis. , 1996, The Journal of pathology.

[9]  M. Volm,et al.  Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. , 1996, British Journal of Cancer.

[10]  M. Toi,et al.  Quantitative analysis of vascular endothelial growth factor in primary breast cancer , 1996, Cancer.

[11]  D M Shames,et al.  Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. , 1996, Radiology.

[12]  T. Sawada,et al.  Prognostic value of vascular endothelial growth factor expression in gastric carcinoma , 1996, Cancer.

[13]  P. Vermeulen,et al.  Long-term results of continuous treatment with recombinant interferon-a in patients with metastatic carcinoid tumors—an antiangiogenic effect? , 1996, Anti-cancer drugs.

[14]  J. Folkman.  Tumor angiogenesis and tissue factor , 1996, Nature Medicine.

[15]  J. Folkman,et al.  Tumoral vascularity as a prognostic factor in cancer. , 1996, Important advances in oncology.

[16]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[17]  S. Fox,et al.  Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. , 1995, Journal of the National Cancer Institute.

[18]  A. Harris,et al.  The increased expression of adhesion molecules ICAM‐3, E‐ and P‐selectins on breast cancer endothelium , 1995, The Journal of pathology.

[19]  P. V. van Diest,et al.  Heterogeneity and reproducibility of microvessel counts in breast cancer. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[20]  A. Gazdar,et al.  Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  A. Choy,et al.  Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery , 1995, The Lancet.

[22]  A. Harris,et al.  Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis , 1995, The Journal of pathology.

[23]  F. Pezzella,et al.  Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  R. Kerbel,et al.  Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. , 1995, Cancer research.

[25]  D B Kopans,et al.  Benign and malignant breast lesions: differentiation with echo-planar MR imaging. , 1995, Radiology.

[26]  R. Mertelsmann,et al.  Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  F. Sarkar,et al.  Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.

[28]  R. Hildenbrand,et al.  Urokinase and macrophages in tumour angiogenesis. , 1995, British Journal of Cancer.

[29]  S. Leinster,et al.  50. Standardizing the methodology of vessel density in breast cancer using immunohistochemistry and tumour microangiography , 1995 .

[30]  P. Lønning,et al.  2. A randomized, double-blind, multicentre crossover trial to evaluate in vivo inhibition of aromatase by Arimidex (ZD1033) (1 mg and 10 mg PO OD) in postmenopausal women with breast cancer , 1995 .

[31]  M. Toi,et al.  Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  Anthony J. Guidi,et al.  Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. , 1995, Journal of the National Cancer Institute.

[33]  N. Weidner.  Intratumor microvessel density as a prognostic factor in cancer. , 1995, The American journal of pathology.

[34]  M. Barbareschi,et al.  Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. , 1995, The cancer journal from Scientific American.

[35]  M. Matsumoto,et al.  Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L Piana,et al.  CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. , 1995, American journal of clinical pathology.

[37]  A. Harris,et al.  Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  T. Shono,et al.  Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. , 1995, Cancer research.

[39]  E. van Marck,et al.  Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. , 1995, British Journal of Cancer.

[40]  K. Chew,et al.  COMMENT ON: TUMOR ANGIOGENESIS AS A PROGNOSTIC ASSAY FOR INVASIVE DUCTAL BREAST CARCINOMA. AUTHORS' REPLY , 1995 .

[41]  Claudio Eccher,et al.  Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computer-aided image analysis system , 1995 .

[42]  E. van Marck,et al.  Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[43]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[44]  H. Augustin,et al.  Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[45]  S. Fox,et al.  Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. , 1994, British journal of urology.

[46]  M. Toi,et al.  Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast Cancer , 1994, Japanese journal of cancer research : Gann.

[47]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[48]  A. Passaniti,et al.  Altered angiogenesis underlying age-dependent changes in tumor growth. , 1994, Journal of the National Cancer Institute.

[49]  P. Black,et al.  Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours , 1994, The Lancet.

[50]  D. G. Altman,et al.  Statistical aspects of prognostic factor studies in oncology. , 1994, British Journal of Cancer.

[51]  J. Bahi,et al.  Angiogenesis and risk of breast cancer in women with fibrocystic disease. , 1994, Journal of the National Cancer Institute.

[52]  Anthony J. Guidi,et al.  Microvessel density and distribution in ductal carcinoma in situ of the breast. , 1994, Journal of the National Cancer Institute.

[53]  W. Kolch,et al.  Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. , 1994, Oncogene.

[54]  N. Weidner,et al.  Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  A. Lindenmayer,et al.  Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[56]  S. Albelda,et al.  Expression of platelet‐endothelial cell adhesion molecule‐1 (PECAM‐1) during melanoma‐induced angiogenesis in vivo , 1993, Journal of cutaneous pathology.

[57]  R Bicknell,et al.  Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. , 1993, Cancer research.

[58]  S. Kumar,et al.  A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues , 1993, International journal of cancer.

[59]  A. Howell,et al.  Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. , 1993, European journal of cancer.

[60]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[61]  A. Harris,et al.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.

[62]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[63]  F. Eschwège,et al.  Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancer. , 1991, Journal of the National Cancer Institute.

[64]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[65]  D. Mason,et al.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. , 1990, Journal of clinical pathology.

[66]  M. Greaves,et al.  Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[67]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[68]  I. Hart,et al.  Metastasis and angiogenesis. , 1990, Acta oncologica.

[69]  D. Ruiter,et al.  Monoclonal antibody-defined human endothelial antigens as vascular markers. , 1989, The Journal of investigative dermatology.

[70]  R. Cotran,et al.  Induction and detection of a human endothelial activation antigen in vivo , 1986, The Journal of experimental medicine.

[71]  K. Bosslet,et al.  Immunohistochemical and immunochemical characterization of a new endothelial cell-specific antigen. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[72]  A. Miettinen,et al.  Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[73]  L. Liotta,et al.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.